Qunol Lawsuit Claims Supplement Dosage Amounts Are Grossly Overstated

New to ClassAction.org? Read our Newswire Disclaimer

A proposed class action lawsuit alleges certain Qunol magnesium, turmeric, CoQ10 and fish oil supplements are falsely advertised in that the products contain only a fraction of the dosage amounts stated on the front labels.

Get class action lawsuit news sent to your inbox – sign up for ClassAction.org’s free weekly newsletter here.

The 29-page Qunol lawsuit against Quten Research Institute says that the supplements’ front labels prominently state a certain dosage amount and number of capsules, gummies or chews in each bottle, leading consumers to falsely believe that each capsule, gummy or chew contains the advertised dosage. However, the case says, consumers must ingest two or more of the supplement capsules, gummies or chews to receive the advertised dosage and have grossly overpaid for dietary products for which they receive “only half or a third of the advertised value.”

According to the complaint, the following Qunol supplements are touted with overstated dosage amounts:

• Extra Strength Magnesium 420 mg;
• Magnesium Gummies 200 mg;
• Extra Strength Turmeric Curcumin Complex 1000 mg;
• Turmeric 2250 mg;
• Turmeric + Ginger 2400 mg;
• Turmeric Gummies 500 mg;
• Turmeric 500 mg + Ginger 50 mg Gummies; 
• Turmeric + Ginger Gummies 550 mg;
• Turmeric + Ginger Chews 750 mg;
• CoQ10 Gummies 100 mg; and
• Ultra Omega-3 Fish Oil 1000 mg.

For example, the case says, a consumer must ingest three capsules of the Qunol Turmeric 2250 mg supplement to achieve the advertised dosage amount of 2,250 mg. As a result, consumers have overpaid for the Qunol supplements by “a significant margin,” the filing alleges.

The suit contends that the label representations on the Qunol supplements at issue are material to reasonable consumers, as dosage amounts and unit representations convey the type and amount of nutrients they will receive after ingesting the products. 

The lawsuit argues that reasonable consumers “are likely to be deceived” by the Qunol supplement labels.

“As a result, Defendant has charged consumers a premium for the Products, while cutting costs and reaping the financial benefits of selling dietary supplements with less than the advertised dosage of nutrients in each Product,” the complaint summarizes.

Per the lawsuit, companies such as Quten Research Institute have rushed to make and sell “purportedly high dosages or more nutrients, at the same or lower costs,” in an effort to gain a leg up on competitors in the market.

The Qunol class action lawsuit looks to cover all United States citizens who bought any of the Qunol supplements listed on this page for personal and household use during the applicable statute of limitations period.

Are you owed unclaimed settlement money? Check out our class action rebates page full of open class action settlements.